MedTrace Logo

An Exploratory, Double-Blind, Placebo-Controlled Study of the Medical Food Vayarin in Children With Autism Spectrum Disorder (ASD)

NCT02222285 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 56

Last updated 2018-04-11

No results posted yet for this study

Summary

The primary study objective is to evaluate the efficacy of Vayarin\_005 on ASD related symptoms in children.

Conditions

  • Autistic Disorder

Interventions

OTHER

Medical Food : Vayarin_005

OTHER

Placebo

Sponsors & Collaborators

  • Enzymotec

    lead INDUSTRY

Principal Investigators

  • Eric Hollander, M.D. · Spectrum Neuroscience and Treatment Institute

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
6 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-08-31
Primary Completion
2017-05-31
Completion
2017-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02222285 on ClinicalTrials.gov